Alnylam’s RNAi Drug Now in Line for Japan Approval in June

Japanese regulators are expected to give their blessing to Alnylam Japan’s RNA interference (RNAi) drug patisiran in June after it cleared a key panel meeting on May 28. It follows the US FDA’s landmark approval last August for the world’s...read more